Janssen HLA - Search Results

1

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.

Murillo Perez CF, Fisher H, Hiu S, Kareithi D, Adekunle F, Mayne T, Malecha E, Ness E, van der Meer AJ, Lammers WJ, Trivedi PJ, Battezzati PM, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Parés A, Londoño MC, Invernizzi P, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Gulamhusein A, Janssen HLA, Smith R, Flack S, Mulcahy V, Trauner M, Bowlus CL, Lindor KD, Corpechot C, Jones D, Mells G, Hirschfield GM, Wason J, Hansen BE; GLOBAL PBC Study Group and the members of the UK-PBC Consortium. Murillo Perez CF, et al. Among authors: janssen hla. Gastroenterology. 2022 Dec;163(6):1630-1642.e3. doi: 10.1053/j.gastro.2022.08.054. Epub 2022 Sep 20. Gastroenterology. 2022. PMID: 36150526 Free article. Clinical Trial.

2

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.

de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. de Jongh FE, et al. Gastroenterology. 1992 Nov;103(5):1630-5. doi: 10.1016/0016-5085(92)91188-a. Gastroenterology. 1992. PMID: 1426884

3

Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection.

Vrolijk JM, Kwekkeboom J, Janssen HL, Hansen BE, Zondervan PE, Osterhaus AD, Schalm SW, Haagmans BL. Vrolijk JM, et al. J Infect Dis. 2003 Nov 15;188(10):1528-32. doi: 10.1086/379334. Epub 2003 Oct 20. J Infect Dis. 2003. PMID: 14624378

4

Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.

Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR, Janssen HL. Darwish Murad S, et al. Hepatology. 2004 Feb;39(2):500-8. doi: 10.1002/hep.20064. Hepatology. 2004. PMID: 14768004 Free article.

5

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL. van Zonneveld M, et al. Hepatology. 2004 Mar;39(3):804-10. doi: 10.1002/hep.20128. Hepatology. 2004. PMID: 14999700

6

Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.

van der Eijk AA, Hansen BE, Niesters HG, Janssen HL, van de Ende M, Schalm SW, de Man RA. van der Eijk AA, et al. J Viral Hepat. 2005 Jul;12(4):364-72. doi: 10.1111/j.1365-2893.2005.00620.x. J Viral Hepat. 2005. PMID: 15985006 Clinical Trial.

7

Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients.

van der Eijk AA, Niesters HG, Hansen BE, Pas SD, Richardus JH, Mostert M, Janssen HL, Schalm SW, de Man RA. van der Eijk AA, et al. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1173-9. doi: 10.1097/00042737-200511000-00004. Eur J Gastroenterol Hepatol. 2005. PMID: 16215428

8

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.

van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA. van der Eijk AA, et al. J Viral Hepat. 2006 Feb;13(2):96-103. doi: 10.1111/j.1365-2893.2005.00661.x. J Viral Hepat. 2006. PMID: 16436127 Clinical Trial.

9

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.

Flink HJ, van Zonneveld M, Hansen BE, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group. Flink HJ, et al. Am J Gastroenterol. 2006 Feb;101(2):297-303. doi: 10.1111/j.1572-0241.2006.00418.x. Am J Gastroenterol. 2006. PMID: 16454834 Clinical Trial.

10

Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.

Flink HJ, Hansen BE, Heathcote EJ, Feinman SV, Simsek H, Karayalcin S, Mach T, Leemans WF, de Man RA, Verhey E, Schalm SW, Janssen HL; HBV 99-01 Study Group. Flink HJ, et al. Am J Gastroenterol. 2006 Nov;101(11):2523-9. doi: 10.1111/j.1572-0241.2006.00812.x. Epub 2006 Oct 4. Am J Gastroenterol. 2006. PMID: 17029610 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

553 results

Search Page